Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications

Authors:

Abstract
Extensive research into the functions of glutamate and glutamate receptors in the CNS has shown an essential role of metabotropic glutamate (mGlu) receptors not only in normal brain functions but also in neurological and psychiatric disorders. The precise functions of these receptors remain undefined and progress toward understanding their functions had been hampered by the lack of selective ligands with appropriate pharmacokinetic properties. The Group I mGlu receptors, comprising mGlu1 and mGlu5 receptors, are well positioned to regulate and fine-tune neuronal excitability and synaptic transmission through its modulation of various signal transduction pathways and interactions with other transmitter systems. Therefore, the mGlu5 receptor may be an important therapeutic target for the treatment of disorders of the CNS. The discovery of MPEP, a non-competitive mGluR5 antagonist, provided a potent, selective, systemically active tool compound for proof-of-concept studies in animal models of various disease...

This publication has 68 references indexed in Scilit: